Tevogen, Inc. (TVGN)
6.05
-0.19
(-3.04%)
USD |
NASDAQ |
Oct 29, 16:00
6.20
+0.15
(+2.48%)
After-Hours: 20:00
Tevogen Market Cap : 25.74M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 25.74M |
| October 28, 2026 | 26.55M |
| October 27, 2026 | 26.72M |
| October 26, 2026 | 26.59M |
| October 23, 2026 | 27.79M |
| October 22, 2026 | 28.98M |
| October 21, 2026 | 27.40M |
| October 20, 2026 | 29.02M |
| October 19, 2026 | 28.81M |
| October 16, 2026 | 30.08M |
| October 15, 2026 | 30.13M |
| October 14, 2026 | 27.68M |
| October 13, 2026 | 30.25M |
| October 12, 2026 | 28.42M |
| October 09, 2026 | 28.85M |
| October 08, 2026 | 30.04M |
| October 07, 2026 | 27.62M |
| October 06, 2026 | 27.62M |
| October 05, 2026 | 28.08M |
| October 02, 2026 | 29.70M |
| October 01, 2026 | 28.59M |
| September 30, 2026 | 28.17M |
| September 29, 2026 | 28.72M |
| September 28, 2026 | 28.76M |
| September 25, 2026 | 30.85M |
| Date | Value |
|---|---|
| September 24, 2026 | 33.40M |
| September 23, 2026 | 33.23M |
| September 22, 2026 | 33.23M |
| September 21, 2026 | 31.62M |
| September 18, 2026 | 33.23M |
| September 17, 2026 | 32.81M |
| September 16, 2026 | 33.19M |
| September 15, 2026 | 32.98M |
| September 14, 2026 | 31.96M |
| September 11, 2026 | 31.32M |
| September 10, 2026 | 31.02M |
| September 09, 2026 | 31.23M |
| September 08, 2026 | 31.19M |
| September 04, 2026 | 31.23M |
| September 03, 2026 | 30.51M |
| September 02, 2026 | 30.51M |
| September 01, 2026 | 30.51M |
| August 31, 2026 | 29.70M |
| August 28, 2026 | 29.32M |
| August 27, 2026 | 28.72M |
| August 26, 2026 | 28.51M |
| August 25, 2026 | 29.66M |
| August 24, 2026 | 28.98M |
| August 21, 2026 | 28.72M |
| August 20, 2026 | 27.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.537B |
| Oncolytics Biotech, Inc. | 53.31M |
| Sangamo Therapeutics, Inc. | 49.67M |
| Sarepta Therapeutics, Inc. | 2.031B |
| Anixa Biosciences, Inc. | 114.13M |
Market Cap Related Metrics
| PEG Ratio | -0.0274 |
| Price | 6.05 |
| Earnings Yield | -96.38% |
| PEGY Ratio | -0.0274 |